Evidence map›Paper›PMID 23143785›Full record

ReviewThe AAPS journal2013

Therapeutic roles of curcumin: lessons learned from clinical trials.

Subash C Gupta, Sridevi Patchva, Bharat B Aggarwal

7 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in The AAPS journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 779 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
779citing papers in PubMed, 11 pooled it
23.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03140657 phase2completednot on this mapstarted 2017, after this paper: background citation

The Effects of Oral Nanocurcumin on Expression Levels of microRNAs and Treg Cells and Th17 Cells Development Factors in Ankylosing Spondylitis Patients

TypeinterventionalSponsorTabriz University of Medical SciencesRan2017 to 2018Enrolled24ConditionsAnkylosing SpondylitisArmsNanocurcumin, Placebo
NCT03845322 early_phase1withdrawnnot on this mapstarted 2018, after this paper: background citation

Clinical Action of Curcumin/Turmeric in Chronic Subdural Hematoma Recurrence

TypeinterventionalSponsorUniversity of New MexicoRan2018 to 2020Enrolled0ConditionsHematoma, Subdural, ChronicArmsCurcumin Pill, Placebo pills
NCT04353310 phase2withdrawnnot on this mapstarted 2021, after this paper: background citation

Evaluating the Effects of Curcumin in Moderate to Severe Asthmatics

TypeinterventionalSponsorLoma Linda UniversityRan2021 to 2021Enrolled0ConditionsAsthmaArmsCurcumin, Placebo
NCT04800107 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

TypeinterventionalSponsorHenry Ford Health SystemRan2021 to 2025Enrolled110ConditionsTinnitus, SubjectiveArmsCurcumin-phosphatidylcholine, Placebo capsule
NCT05062486 phase2completednot on this mapstarted 2021, after this paper: background citation

An Open-Label, Randomized, Double Arm, Phase 2 Study to Evaluate the Safety and Efficacy of C and RQC for Preventing Progression in Age-Related Macular Degeneration

TypeinterventionalSponsorPaul A Knepper, MD PhDRan2021 to 2024Enrolled55ConditionsAge-related Macular DegenerationArmsResveratrol, Quercetin, Curcumin (RQC), Curcumin
NCT07436130 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Immunomodulatory Effect of Curcumin in Critically Ill Patients With Sepsis at the Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde": A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

TypeinterventionalSponsorHospital Civil de GuadalajaraRan2026 to 2027Enrolled56ConditionsSepsisArmsCurcumin, Placebo
NCT07753018 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of the Effect of Curcumin and Piperine Supplementation on Clinical Outcome in Fibromyalgia Patients.

TypeinterventionalSponsorAin Shams UniversityRan2026 to 2027Enrolled80ConditionsFibromyalgia (FM)ArmsCurcumin - Piperine, Placebo
3 · Its place in the literature

Who cites it

779 citing papers in PubMed, 11 syntheses or guidelines pooled it, 2,010 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. The validity of over-the-counter skin, hair, and nail recommendations for adult patients with cancer: A systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. [Explore the potential diagnostic markers of primary Sjögren syndrome by bioinformatics combined with machine learning].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

719 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Subash C GuptaCytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Road, Unit # 1950, Houston, TX 77054, USA.
Sridevi Patchva
Bharat B Aggarwal
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensive research over the past half century has shown that curcumin (diferuloylmethane), a component of the golden spice turmeric (Curcuma longa), can modulate multiple cell signaling pathways. Extensive clinical trials over the past quarter century have addressed the pharmacokinetics, safety, and efficacy of this nutraceutical against numerous diseases in humans. Some promising effects have been observed in patients with various pro-inflammatory diseases including cancer, cardiovascular disease, arthritis, uveitis, ulcerative proctitis, Crohn's disease, ulcerative colitis, irritable bowel disease, tropical pancreatitis, peptic ulcer, gastric ulcer, idiopathic orbital inflammatory pseudotumor, oral lichen planus, gastric inflammation, vitiligo, psoriasis, acute coronary syndrome, atherosclerosis, diabetes, diabetic nephropathy, diabetic microangiopathy, lupus nephritis, renal conditions, acquired immunodeficiency syndrome, β-thalassemia, biliary dyskinesia, Dejerine-Sottas disease, cholecystitis, and chronic bacterial prostatitis. Curcumin has also shown protection against hepatic conditions, chronic arsenic exposure, and alcohol intoxication. Dose-escalating studies have indicated the safety of curcumin at doses as high as 12 g/day over 3 months. Curcumin's pleiotropic activities emanate from its ability to modulate numerous signaling molecules such as pro-inflammatory cytokines, apoptotic proteins, NF-κB, cyclooxygenase-2, 5-LOX, STAT3, C-reactive protein, prostaglandin E(2), prostate-specific antigen, adhesion molecules, phosphorylase kinase, transforming growth factor-β, triglyceride, ET-1, creatinine, HO-1, AST, and ALT in human participants. In clinical trials, curcumin has been used either alone or in combination with other agents. Various formulations of curcumin, including nanoparticles, liposomal encapsulation, emulsions, capsules, tablets, and powder, have been examined. In this review, we discuss in detail the various human diseases in which the effect of curcumin has been investigated.

Indexed as

Clinical Trials as TopicArthritisCurcuminHumansInflammatory Bowel DiseasesIrritable Bowel SyndromeNeoplasmsPeptic UlcerVitiligoCurcumin

Identifiers

PMID23143785
PMCPMC3535097
OpenAlexW2077166822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.